Vaulta price

Akiki Sato participated in the 2015 $ADA voucher sale. Should have bought more. 🥲

Fosun has a Hong Kong-listed company called Sisram Medical, with a market capitalization of $330 million, and yesterday officially announced that Fosun tokenized its shares and sent them to the chain. It chose four chains, namely Vaulta, SOL, ETH, and Sonic. According to common sense, a large group like Fosun, even if it is a business that empowers a certain business, is enough to establish a new company. This type of subsidiary initially empowered the company, and then slowly began to accept external customer orders, coupled with capital operation, and often had the opportunity to go public. The person in charge of this RWA business is FinChain, a new company that Fosun has just incubated, and FinChain is clearly positioned as Fosun's Web3/RWA business line. Vaulta is a key partner of FinChain. For a successful issuance of an RWA, it requires at least four roles: asset owner, service provider (including solution, audit, development, law firm, etc.), public chain, and distributor. Therefore, a company under Fosun should be the asset owner this time, and FinChain is the service party, and Vaulta, as the public chain party, is likely to also be involved in the development of FinChain (such as Vaulta's Banking OS system), so Vaulta can undertake the RWA business of listed companies like Furui Medical. Of course, there are still certain requirements to act as a public chain party, because supervision often has to review the qualifications of all relevant parties, including public chains. Only a regulatory-recognized public chain has the opportunity to become the bearer chain of RWA tokens. Therefore, veteran public chains that have been running steadily for many years are more popular in the RWA field. $A